4.7 Article

Default mode network connectivity in stable vs progressive mild cognitive impairment

Journal

NEUROLOGY
Volume 76, Issue 6, Pages 511-517

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/WNL.0b013e31820af94e

Keywords

-

Funding

  1. NIH/NIA [1R01AG019728]
  2. Avid Radiopharmaceuticals, Inc.
  3. Pfizer Inc
  4. Eisai Inc.
  5. NIH
  6. National Science Foundation
  7. US Department of Energy
  8. Otsuka Pharmaceutical Co., Ltd.
  9. Bristol-Myers Squibb
  10. Alzheimer's Association
  11. Accera, Inc.
  12. Neuroptix Corporation
  13. Neuronetrix, Inc.
  14. Medivation, Inc.
  15. GE Healthcare
  16. TauRx Pharmaceuticals
  17. Lundbeck Inc.
  18. Forest Laboratories, Inc.
  19. Elan Corporation
  20. Eli Lilly and Company
  21. Ono Pharmaceutical Co. Ltd.
  22. sanofi-aventis
  23. Novartis
  24. GlaxoSmithKline
  25. NIH (NIA/NIMH/NINDS)
  26. NARSAD
  27. American Federation for Aging Research
  28. Alzheimer's Drug Discovery Foundation

Ask authors/readers for more resources

Objective: Dysfunction of the default mode network (DMN) has been identified in prior cross-sectional fMRI studies of Alzheimer disease (AD) and mild cognitive impairment (MCI); however, no studies have examined its utility in predicting future cognitive decline. Methods: fMRI scans during a face-name memory task were acquired from a cohort of 68 subjects (25 normal control, 31 MCI, and 12 AD). Subjects with MCI were followed for 2.4 years (+/-0.8) to determine progression to AD. Maps of DMN connectivity were compared with a template DMN map constructed from elderly normal controls to obtain goodness-of-fit (GOF) indices of DMN expression. Indices were compared between groups and correlated with cognitive decline. Results: GOF indices were highest in normal controls, intermediate in MCI, and lowest in AD (p < 0.0001). In a predictive model (that included baseline GOF indices, age, education, Mini-Mental State Examination score, and an index of DMN gray matter volume), the effect of GOF index on progression from MCI to dementia was significant. In MCI, baseline GOF indices were correlated with change from baseline in functional status (Clinical Dementia Rating-sum of boxes) (r = - 0.40, p < 0.04). However, there was no additional predictive value for DMN connectivity when baseline delayed recall was included in the models. Conclusions: fMRI connectivity indices distinguish patients with MCI who undergo cognitive decline and conversion to AD from those who remain stable over a 2- to 3-year follow-up period. Our data support the notion of different functional brain connectivity endophenotypes for early vs late MCI, which are associated with different baseline memory scores and different rates of progression and conversion. Neurology (R) 2011; 76: 511-517

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available